Abstract
Parathyroid hormone–related peptide (PTHrP) was found to improve contractile function of stunned myocardium in pigs. The peptide is released from coronary endothelial cells during ischemia and significantly improves post–ischemic recovery. The present study was aimed to decide whether such an induction of contractile responsiveness of the heart requires co–activation of adjacent cells or is a genuine phenomenon of cardiomyocytes. A second aim of this study was to decide whether such an improvement is linked to depressed cell function in general or oxidative inhibition. Isolated adult ventricular cardiomyocytes from rats were constantly paced at 0.5 Hz for 10 min. Cells were exposed to a brief oxidative inhibition by addition of 0.5 mmol/l potassium cyanide (KCN) in the presence of glucose. Under these conditions, cells stopped beating after 280 s on average. 30 s before they stopped to beat, cells had already developed a reduction in cell shortening, maximal relaxation and contraction velocity. In the co–presence of PTHrP (1–34) (100 nmol/l) cells continued to beat regular and did not develop reduced cell shortening, irrespectively of oxidative inhibition. In a second attempt, cells were exposed to the NO donor SNAP (100 µmol/l) or 8–bromocGMP (1 mmol/l). As expected both agents reduced cell shortening significantly. This reduction in cell shortening was attenuated in co–presence of PTHrP, too. Finally, we investigated the effect of PTHrP on cell shortening at different extracellular concentrations of calcium. Although, PTHrP increased intracellular calcium at 2 and 5 mmol/l extracellular calcium, respectively, it improved cell shortening only at 5 mmol/l extracellular calcium. Thus, the beneficial effect of PTHrP on cell shortening was independent from intracellular calcium but dependent on the steepness of the calcium gradient between intra– and extracellular calcium. In conclusion, our study shows that PTHrP is able to improve cell shortening rapidly and directly irrespectively of the reason for the reduced cell function. Improved electromechanical coupling rather than intracellular calcium handling seems to be the most important mechanism.
Similar content being viewed by others
References
Brady AJB, Warren JB, Poole–Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocytes contraction. Am J Physiol Heart Circ Physiol 265:H176–H182
Bui TD, Shallal A, Malik AN, Al–Mahdawi S, Mosocos G, Bailey MES, Burton PBJ, Moniz C (1993) Parathyroid hormonerelated peptide gene expression in human fetal and adult heart. Cardiovasc Res 27:1204–1208
Burton DW, Brandt DW, Deftos LJ (1994) Parathyroid hormone–related protein in the cardiovascular system. Endocrinology 135:253–261
Caldarone CA, Krukenkamp IB, Burns PG, Misare BD, Gaudette GR, Levitsky S (1994) Ischemia–dependent efficacy of phosphodiesterase inhibition. Ann Thorac Surg 57:540–545
Grohé C, van Eickels M, Wenzel S, Meyer R, Degenhardt H, Doevendans PA, Heinemann MP, Ross G, Schlüter K–D (2004) Sex–specific differences in ventricular expression and function of parathyroid hormone–related peptide. Cardiovasc Res 61:307–316
Hempel A, Friedrich M, Schlüter K–D, Forssmann WG, Huhn M, Piper HM (1997) ANP protects against reoxygenation– induced hypertcontracture in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 273:H244–H249
Heusch G, Schulz R (2001) Perfusioncontraction match and mismatch. Basic Res Cardiol 96:1–10
Hofstaetter B, Taimor G, Inserte J, Garcia– Dorado D, Piper HM (2002) Inhibition of apoptotic responses after ischemic stress in isolated hearts and cardiomyocytes. Basic Res Cardiol 97:497–488
Jansen J, Gres P, Umschlag C, Heinzel FR, Degenhardt H, Schlüter K–D, Heusch G, Schulz R (2001) Parathyroid hormonerelated peptide improves contractile function of stunned myocardium in rats and pigs. Am J Physiol Heart Circ Physiol 284:H49–H54
Jüngling E, Kammermeier H (1980) Rapid bioassay of adenine nucleotides or creatine compounds in extracts of cardiac tissue by paired–ion reverse–phase high performance liquid chromatography. Anal Biochem 102:358–361
Kojda G, Kottenberg K, Nix P, Schlüter K–D, Piper HM, Noack E (1996) Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78:91–101
Kondo RP, Apstein CS, Eberli FR, Tillotson DL, Suter TM (1998) Increased calcium loading and inotropy without greater cell death in hypoxic rat cardiomyocytes. Am J Physiol Heart Circ Physiol 275:H2272–H2282
Ladilov YV, Balser–Schäfer C, Haffner S, Maxeiner H, Piper HM (1999) Pretreatment with PKC activator protects cardiomyocytes against reoxygenationinduced hypercontracture independently of Ca2+ overload. Cardiovasc Res 43:408–416
Ladilov YV, Efe Ö, Schäfer C, Rother B, Kasseckert S, Abdallah Y, Meuter K, Schlüter K–D, Piper HM (2003) Reoxygenation– induced rigor–type contracture. J Mol Cell Cardiol 35:1481–1490
Ladilov YV, Siegmund B, Piper HM (1995) Protection of reoxygenated cardiomyocytes against simulated ischemia and reoxygenation by inhibition of the Na+/H+ exchange. Am J Physiol Heart Circ Physiol 268:H1531–H1539
Lamprecht W, Stein P, Heinz F, Weisser H (1974) Creatine phosphate. In: Bergmeyer HU (ed) Methoden der Enzymatischen Analyse. Verlag Chemie, Weinheim, pp 1825–1829
Langer M, Lüttecke D, Schlüter K–D (2003) Mechanism of the positive contractile effect of nitric oxide on rat ventricular cardiomyocytes with positive force/frequency relationship. Pflugers Arch – Eur J Physiol 447:289–297
Lasley RD, Jahania MS, Mentzer RM (2001) Beneficial effects of adenosine A2a agonist CGS–21680 in infracted and stunned porcine myocardium. Am J Physiol Heart Circ Physiol 280:H1660–H1666
Ogino K, Burkhoff D, Bilezikian JP (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH–related protein. Endocrinology 136:3024–3030
Patel KN, Yan L, Gandhi A, Scholz PM, Weiss HR (2001) Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes. Basic Res Cardiol 96:34–41
Roca–Cusachs A, DiPette DJ, Nickols GA (1991) Regional and systemic hemodynamic effects of parathyroid hormonerelated protein: Preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther 256:110–118
Schlüter K–D, Katzer C, Frischkopf K, Wenzel S, Taimor G, Piper HM (2000) Expression, release, and biological activity of parathyroid hormone–related peptide from coronary endothelial cells. Circ Res 86:946–581
Schlüter K–D, Schreiber D (2004) Adult ventricular cardiomyocytes: Isolation and Culture. In: Helgason CD, Miller CL (eds) Methods in Molecular Biology, Humana Press, pp 305–314
Schlüter K–D, Weber M, Piper HM (1997) Effects of PTHrP(107–111) and PTHrP(7– 34) on adult cardiomyocytes. J Mol Cell Cardiol 29:3057–3065
Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG (1994) 8–bromo–cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 74:970–978
Siegmund B, Koop A, Piper HM (1989) The use of the creatine kinase reaction to determine free energy change of ATP hydrolysis in anoxic cardiomyocytes. Pflugers Arch – Eur J Physiol 413: 435–437
Smogorzewski M, Zayed M, Zhang Y–B, Roe J, Massry SG (1993) Parathyroid hormone increases cytosolic calcium concentration in adult cardiac myocytes. Am J Physiol Hear Circ Physiol 264:H1998–H2006
Suematsu N, Satoh S, Ueda Y, Makino N (2002) Effects of calmodulin and okadaic acid on myofibrillar Ca2+ sensitivity in cardiac myocytes. Basic Res Cardiol 97:137–144
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lütteke, D., Ross, G., Abdallah, Y. et al. Parathyroid hormone–related peptide improves contractile responsiveness of adult rat cardiomyocytes with depressed cell function irrespectively of oxidative inhibition. Basic Res Cardiol 100, 320–327 (2005). https://doi.org/10.1007/s00395-005-0532-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00395-005-0532-9